Aminosin 5% (IV Infusion)

500 ml bottle: ৳ 350.00

Medicine Details

Indications

  • Source of amino acids for protein synthesis
  • Suitable for patients with basal amino acid requirements
  • Faster recovery in surgery, burns, renal insufficiency, hepatic insufficiency, and cancer management

Composition

  • EssentialAminoAcids:
    • L-Isoleucine
    • L-Leucine
    • L-Lysine Hydrochloride
    • L-Methionine
    • L-Phenylalanine
    • L-Threonine
    • L-Tryptophan
    • L-Valine
    • L-Histidine
    • L-Tyrosine
  • NonEssentialAminoAcids:
    • L-Arginine
    • L-Aspartic Acid
    • L-Glutamic Acid
    • L-Alanine
    • L-Cystine
    • Glycine (Aminoacetic Acid)
    • L-Proline
    • L-Serine
  • Excipients: D-Sorbitol
  • Electrolytes:
    • Sodium (Na+)
    • Potassium (K+)
    • Magnesium (Mg++)
    • Chloride (Cl-)
    • Acetate (CH3COO-)
  • TotalNitrogenContent: 7.25 gm/L
  • TotalEnergyContent: 1551 kj/L (371.14 Kcal/L)

Pharmacology

  • Sterile aqueous solution of crystalline Amino Acid and D-Sorbitol with electrolytes
  • Contains all 18 essential and non-essential amino acids for protein synthesis
  • Clear, colorless to pale yellow colored
  • pH range of 5.0 to 7.0

Dosage & Administration

  • Adults:
    • 0.10-0.25 g nitrogen/kg/day
    • 15-35 ml Amino acids IV/kg/day
  • ObesePatients: Dose based on estimated ideal weight
  • Children&Infants: 28-35 ml/kg body weight per day

Interaction

No expected pharmacological effects or interactions with other medicaments

Contraindications

  • Inborn errors of amino acids metabolism
  • Severe liver dysfunction
  • Severe uremia without dialysis facilities
  • Hyperosmolar nonketotic diabetic coma

SideEffects

  • Rarely nausea
  • Vomiting and sweating at high infusion rates
  • Transient increases in liver test
  • Hypersensitivity reactions
  • Thrombophlebitis risk
  • Hyperphenylalaninemia in severely ill, premature infants

Pregnancy & Lactation

Reported successful and safe administration during pregnancy in humans

Precautions & Warnings

  • IncreasedUrinaryExcretion: Trace elements copper and zinc
  • HyperphenylalaninemiaMonitoring: Recommended for severely ill, premature infants
  • CautionInUseWith:
    • Diabetes mellitus
    • Severe heart failure
    • Renal function with fluid restrictions or oliguria/anuria
    • Severely malnourished patients
  • MonitoringRecommendation:
    • Serum potassium
    • Blood glucose
  • AdditionalPhosphateSupply: Recommended for patients with hypophosphatemia

OverdoseEffects

  • RiskOf:
    • Nausea
    • Vomiting
    • Sweating
    • Thrombophlebitis
    • Osmotic diuresis
    • Hyperglycemia symptoms
  • Management: Slow down or discontinue infusion in case of overdose symptoms

TherapeuticClass

Parenteral nutritional preparations

StorageConditions

  • Temperature: Between 15°C to 25°C
  • Precaution: Protect from light and avoid freezing
  • Safety: Keep out of reach of children

Related Brands